Imidacloprid + Moxidectin (Advantage Multi, Imoxi): adverse event reports that FDA received
Combination of 2 active ingredients
Also sold as: Advantage Multi, Imoxi, Parasedge Multi, Midamox, Barrier, MoxiCloprid.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Read this first. FDA says this about the data:
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .
This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.
Contacting a veterinarianHow to report to FDAFrom June 2006 to June 2026, FDA received 23,348 adverse event reports that name a drug with imidacloprid and moxidectin as its active ingredients. Of the 23,348 reports, 13,117 (56.2%) are about dogs. 8,157 reports are about cats (34.9%).
In January to March 2026, FDA received 101 reports that name this drug. The signs that appear in the largest number of the 23,348 reports are "Lethargy", "Pruritus" and "Lack of efficacy (ectoparasite) - flea". A report is not proof that a drug caused a sign.
Reports that name this drug fell by 17.3% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about cats are 34.9% of the reports that name this drug, and 11% of all reports.
Since the last update of the FDA data
The site recorded an update of the FDA data on . FDA changed these counts for January to March 2026:
- All species: from 92 to 101.
- Dog: from 69 to 77.
January to March 2026 is the latest closed quarter in the data. In that quarter FDA received 101 reports that name imidacloprid + moxidectin: 77 dog, 18 cat, 0 horse, 6 other or not given.
Signs that the reports list
A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 23,348 reports that list the sign. One report can list more than one sign.
The sign that is in the largest number of the reports comes first.
- Lethargy[unusually tired or inactive]11.4%2,653 reports
- Pruritus[itching]10.9%2,547 reports
- Lack of efficacy (ectoparasite) - flea[the product did not have the expected effect: fleas]10.3%2,411 reports
- Vomiting9.3%2,181 reports
- Behavioural disorder NOS[behaviour change, type not specified]8.9%2,088 reports
- Hypersalivation[drooling]7.4%1,718 reports
- Anorexia[not eating]5.8%1,356 reports
- Diarrhoea[diarrhea]5.4%1,263 reports
- Application site alopecia[hair loss where the product was applied]5.2%1,209 reports
- Ataxia[unsteady, uncoordinated movement]4.8%1,124 reports
- Other abnormal test result NOS[abnormal laboratory result, type not specified]4.2%991 reports
- Lack of efficacy (endoparasite) - heartworm[the product did not have the expected effect: heartworm]3.8%887 reports
- Underfilling, Tubes[a product quality report, not a sign in an animal]3.6%847 reports
- Hyperactivity3.6%838 reports
Show the next 16 signs
- Accidental exposure[exposure that was not intended]3.4%804 reports
- Ineffective, heartworm larvae[legacy FDA term: the product did not have the expected effect (heartworm larvae)]3.3%774 reports
- Depression[dull, quiet or withdrawn]3.3%760 reports
- Application site pruritus[itching where the product was applied]3.1%717 reports
- Agitation2.6%603 reports
- Application site erythema[reddened skin where the product was applied]2.5%578 reports
- Seizure NOS[seizure, type not specified]2.4%559 reports
- Death2.3%536 reports
- Uncoded sign[a sign with no matching dictionary term]2.1%483 reports
- Vocalisation[crying out or unusual noise]2%471 reports
- Weight loss1.9%454 reports
- Hiding1.8%417 reports
- Application site reaction NOS[reaction nos where the product was applied]1.7%406 reports
- Lack of efficacy (endoparasite) - hookworm[the product did not have the expected effect: hookworms]1.7%400 reports
- Emesis (multiple)[vomiting more than once]1.6%374 reports
- Muscle tremor1.6%368 reports
The list shows 30 of 1,626 coded signs. A report is not proof that a drug caused a sign. Download all signs (CSV)
Reports by species
The share is of all 23,348 reports that name imidacloprid + moxidectin. The other reports give a different species or no species.
Reports for each month, Jul 2021 to Jun 2026
No chart: no month has 5 or more reports.
The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
Reports by year
- Dog
- Cat
- Horse
- Other or not given
| Year | Dog | Cat | Horse | Other or not given | All species |
|---|---|---|---|---|---|
| 2026 | 165 | 45 | 0 | 16 | 226 |
| 2025 | 347 | 110 | 0 | 44 | 501 |
| 2024 | 499 | 125 | 0 | 41 | 665 |
| 2023 | 402 | 180 | 0 | 63 | 645 |
| 2022 | 454 | 225 | 0 | 35 | 714 |
| 2021 | 542 | 292 | 0 | 82 | 916 |
| 2020 | 743 | 433 | 0 | 135 | 1,311 |
| 2019 | 921 | 496 | 0 | 157 | 1,574 |
| 2018 | 933 | 585 | 0 | 151 | 1,669 |
| 2017 | 1,047 | 732 | 0 | 150 | 1,929 |
| 2016 | 766 | 539 | 0 | 134 | 1,439 |
| 2015 | 804 | 560 | 0 | 152 | 1,516 |
| 2014 | 949 | 553 | 0 | 162 | 1,664 |
| 2013 | 973 | 596 | 0 | 182 | 1,751 |
| 2012 | 1,030 | 612 | 0 | 157 | 1,799 |
| 2011 | 778 | 575 | 0 | 172 | 1,525 |
| 2010 | 741 | 532 | 0 | 89 | 1,362 |
| 2009 | 491 | 502 | 0 | 77 | 1,070 |
| 2008 | 293 | 289 | 0 | 50 | 632 |
| 2007 | 237 | 175 | 0 | 25 | 437 |
| 2006 | 2 | 1 | 0 | 0 | 3 |
2026 has the reports that FDA received through Jun 2026. Download the years (CSV)
What the reports record
Outcome at the time of the report
- Recovered/Normal30.7%7,172
- Recovered with Sequela[recovered, with a lasting effect]0.2%42
- Ongoing3.8%881
- Died2.6%618
- Euthanized1.4%322
- Outcome Unknown41.7%9,739
An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 23,348 reports that name imidacloprid + moxidectin.
A report about more than one animal can have more than one outcome.
Kind of report
- Safety issue84.7%19,785
- Lack of expected effectiveness5%1,161
- Both safety and lack of expected effectiveness3.1%717
- Manufacturing or product defect7.2%1,680
- Otherunder 0.1%5
18,622 reports say if the event was serious. 64.8% of them have the serious flag. The person who sends the report sets the flag.
Show age, weight, breed and route
Age of the animal
- Under 1 year13.4%3,124
- 1 to 3 years27.4%6,406
- 4 to 7 years21.4%4,986
- 8 to 11 years13.5%3,156
- 12 years and over9%2,100
- Age not given15.3%3,576
Weight of the animal
- Under 5 kg (11 lb)30.6%7,148
- 5 to 9.9 kg (11 to 22 lb)23.3%5,438
- 10 to 24.9 kg (22 to 55 lb)14.1%3,292
- 25 to 44.9 kg (55 to 99 lb)12.8%2,982
- 45 kg and over (99 lb and over)1.7%390
- Weight not given17.6%4,098
Breed, where the report gives one breed
- Domestic Shorthair16.9%3,956
- Domestic5.4%1,250
- Labrador Retriever3.7%862
- Domestic Longhair2.6%615
- Chihuahua2.6%615
- Yorkshire Terrier2.6%604
- Shih Tzu2.1%481
- Domestic Mediumhair1.7%390
A breed with many animals has many reports.
Route in the report
- Topical86.1%20,096
- Oral3.3%778
- Other2%473
- Intraocular0.1%28
- Ophthalmic0.1%26
- Respiratory (Inhalation)0.1%23
Each bar is on a scale of 0 to 100%.
Approved animal drugs with these active ingredients (FDA Green Book)
This section is reference data. It has no report count.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Brand names
- Advantage Multi
- Imoxi
- Parasedge Multi
- Midamox
- Barrier
- MoxiCloprid
What the Green Book records give
- Applications with an approval in force
- 12
- Approved species
- Cats, Dogs, Ferrets
- Dose forms
- Topical Solution, Liquid (Solution), Solution
- Routes
- Topical
- Sale
- RX (prescription)
- Earliest approval date in the records
The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.
| Brand name | Active ingredients | Sponsor | Approved species | Application |
|---|---|---|---|---|
| Advantage Multi for Dogs | Imidacloprid, Moxidectin | Elanco US Inc. | Dogs | NADA 141-251 |
| Advantage multi for cats | Imidacloprid, Moxidectin | Elanco US Inc. | Cats | NADA 141-254 |
| Imoxi Topical Solution for Dogs | Imidacloprid, Moxidectin | Vetoquinol USA, Inc. | Dogs | ANADA 200-615 |
| Imoxi Topical Solution for Cats | Imidacloprid, Moxidectin | Vetoquinol USA, Inc. | Cats | ANADA 200-638 |
| Parasedge Multi for Dogs | Imidacloprid, Moxidectin | Virbac AH, Inc. | Dogs | ANADA 200-700 |
| Parasedge Multi for Cats | Imidacloprid, Moxidectin | Virbac AH, Inc. | Cats | ANADA 200-701 |
| Barrier for cats | Imidacloprid, Moxidectin | Aurora Pharmaceutical, Inc. | Cats | ANADA 200-714 |
| Midamox for Dogs | Imidacloprid, Moxidectin | Norbrook Laboratories, Ltd. | Dogs | ANADA 200-716 |
| Barrier for dogs | Imidacloprid, Moxidectin | Aurora Pharmaceutical, Inc. | Dogs | ANADA 200-718 |
| Midamox for Cats | Imidacloprid, Moxidectin | Norbrook Laboratories, Ltd. | Cats | ANADA 200-721 |
| MoxiCloprid for Cats | Imidacloprid, Moxidectin | Bimeda Animal Health Ltd. | Cats | ANADA 200-811 |
| MoxiCloprid for Dogs | Imidacloprid, Moxidectin | Bimeda Animal Health Ltd. | Dogs | ANADA 200-818 |
Other pages with one of these ingredients
A report names a drug by its set of active ingredients. Each set has its own page. The list is in order of name.
Next in the A to Z list
FDA pages for this drug
- How to Report Animal Drug and Device Side Effects and Product ProblemsThe FDA page that tells an owner or a veterinarian how to send a report.
- Green Book record of NADA 141-251The FDA record of the application for Advantage Multi for Dogs.
- Green Book record of ANADA 200-615The FDA record of the application for Imoxi Topical Solution for Dogs.
- Green Book record of ANADA 200-700The FDA record of the application for Parasedge Multi for Dogs.
- Green Book record of ANADA 200-716The FDA record of the application for Midamox for Dogs.
- Green Book record of ANADA 200-718The FDA record of the application for Barrier for dogs.
- Green Book record of ANADA 200-818The FDA record of the application for MoxiCloprid for Dogs.
- Animal Drugs @ FDAThe search page of the Green Book, the FDA list of approved animal drugs.
The site checked these addresses on . The links open in a new tab.
Cite this page
Pet Drug Reports. Imidacloprid + Moxidectin: adverse event reports that FDA received. https://petdrugreports.com/drug/imidacloprid-moxidectin/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .
Where the data come from
The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. The site does not use the application number that a record has.
The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.
Questions about these reports
- Which brand are these reports about?
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists the brand names with these active ingredients.
- Do the reports show that the drug caused the signs?
No. FDA states this about the data.
When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.
The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
- How many reports did FDA receive in the latest 12 months?
FDA received 482 reports in the 12 months to June 2026. It received 583 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
- What kinds of report are in the count?
Of the 23,348 reports received from June 2006 to June 2026, 84.7% are about a safety issue only. 8% are about a lack of expected effectiveness, alone or with a safety issue. 7.2% are about a defect of the product or its package.